Navigation Links
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Date:2/23/2009

BETHESDA, Md., Feb. 23 /PRNewswire/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that Dr. Kapil Dhingra has joined its Board of Directors, effective as of February 18, 2009. As a result of Dr. Dhingra's appointment, the Board is now comprised of nine members.

Dr. Dhingra has been active in oncology clinical research for over 20 years. During his tenure at Hoffmann-La Roche from 1999 to 2008, he built the largest oncology clinical development department in the industry. Dr. Dhingra provided strategic development leadership resulting in a successful track record of global oncology drug approvals, including numerous indications for Herceptin(R), MabThera(R), Xeloda(R), Bondronat(R), Tarceva(R) and Avastin(R). In his academic career, Dr. Dhingra received several research grants from the National Cancer Institute as well as from major oncology pharmaceutical and biotechnology companies and built an impressive record of publications in peer-reviewed journals.

"We are honored to have Dr. Dhingra join the Board of Directors," said David F. Hale, Chairman of the Board of Micromet. "His significant success and proven track record in the development of oncology drugs will be a tremendous asset to Micromet as we advance our clinical stage product candidates to pivotal trials."

"Micromet's BiTE antibodies have the potential to become the next big breakthrough in cancer therapy. Having taken part in the successful development of the first generation of therapeutic antibodies for the treatment of various cancers, I look forward to working with the board and management of Micromet and contributing to the development of its BiTE antibodies and other clinical stage product candidates.
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Northwest Biotherapeutics (NASDAQ: ... ® personalized immune therapies for solid tumor cancers, ... this year,s American Society Of Clinical Oncology (ASCO) meeting ... leadership role in immune therapy.  (Logo: ... is the pre-eminent conference focused on clinical treatment of ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... African-Americans in STEM industries, Black Data Processing Associates (BDPA), ... Day on June 8, 2013. This all-day event will ... arena, and learn the ins and outs from many ... to 3 p.m. at the New Jersey Institute of ...
(Date:5/23/2013)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... a teleconference to discuss its First Quarter 2013 financial ... information is provided below: Date: Thursday, May ... Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 ( ... For those unable to participate in the ...
(Date:5/23/2013)... May 23, 2013  Verenium Corporation (Nasdaq: ... the development and commercialization of high-performance enzymes, today announced ... Officer, will present at two upcoming conferences. ... present at the Second Annual Marcum LLP Microcap Conference ... Hotel in New York City.  The presentation is scheduled ...
Breaking Biology Technology:NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3
... Medical,Innovations, Inc. (Amex: IMA ), a leading ... consumer and professional markets, announced,today that it will ... and Mid,(Smid) Cap Conference being held March 26-27, ... Zwanziger, Chief Executive Officer, and Jon Russell,Vice President, ...
... Corporation today,announced that Blake M. Paterson M.D., its ... Bioscience Award from the Greater Baltimore Council.,Dr. Paterson ... by businesses, bioscience advocates, higher education,institutions and government ... Paterson has received this award from the Greater ...
... Pursuant to NASDAQ,Marketplace Rule 4350(b)(1)(B) (the "NASDAQ ... of the NASDAQ stock exchanges that receives a,going ... with the Securities and,Exchange Commission is required to ... this NASDAQ Rule, Insmed Incorporated (Nasdaq:,INSM), today announced ...
Cached Biology Technology:Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008 2Blake M. Paterson MD, CEO and Co-founder of Alba Therapeutics, Wins Greater Baltimore Committee 2008 Leadership in Bioscience Award 2Insmed Announces Additional Information in Compliance With NASDAQ Rules 2
(Date:5/22/2013)... Forest Service scientists are part of "Landscapes of Resilience", ... Foundation, will examine how collaborative planning and stewardship of ... , The TKF Foundation announced today that Landscapes of ... funding. In addition to research on the role of ... the 3-year, $585,000 grant will contribute to the creation ...
(Date:5/22/2013)... National Lung Screening Trial (NLST) investigators also conclude ... mortality with low-dose computed tomography (LDCT) versus chest ... primary paper is achievable at experienced screening centers ... more information to share with their patients about ... screening following today,s publication in the New ...
(Date:5/22/2013)... working to improve durability in fuel cell powered ... have discovered links between electrode degradation processes and ... the effects of electrode degradation stressors in the ... lifetime. , The findings of the study, led ... latest in a long-term study at Burnaby-based Ballard ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Tests lead to doubling of fuel cell life 2
... Salk Institute for Biological Studies have identified a novel ... burn fat, a discovery that suggests new ways to ... , Genetically engineered mice, in which the pathway was ... a high-fat diet, the Salk team led by Marc ...
... household cleaners and air fresheners emit toxic pollutants at ... a new study by researchers at the University of ... levels to some of the pollutants ?and to the ... with ozone ?may exceed regulatory guidelines when a large ...
... San Diego (UCSD) School of Medicine shows that liver ... death and renewal. , The research, appearing online the ... the journal Proceedings of the National Academy of Sciences, ... proliferation. The findings by Michael Karin, Ph.D., professor ...
Cached Biology News:Chewing up a key regulator of fat synthesis keeps mice lean despite a high-fat diet 2Chewing up a key regulator of fat synthesis keeps mice lean despite a high-fat diet 3Many cleaners, air fresheners may pose health risks when used indoors 2Many cleaners, air fresheners may pose health risks when used indoors 3Many cleaners, air fresheners may pose health risks when used indoors 4Many cleaners, air fresheners may pose health risks when used indoors 5Many cleaners, air fresheners may pose health risks when used indoors 6Cycles of cell death, proliferation key to liver cancer 2